View source for Borrelia miyamotoi

{{DISPLAYTITLE:''Borrelia miyamotoi''}}

== Background ==

* Tick-borne infection
* Transmitted by hard-body ticks, including [[Vector::Ixodes scapularis]] (in northeastern and nortcentral North America), [[Vector::Ixodes pacificus]] (in northwestern North America), [[Vector::Ixodes ricinus]] (in Europe), [[Vector::Ixodes persulcatus]] (in Europe and Asia), and [[Vector::Ixodes ovatus]], [[Vector::Ixodes nipponensis]], and [[Vector::Ixodes pavoloskyi]] (in Asia)
* Present worldwide, including Canada

== Clinical Manifestations ==

* In immunocompetent patients, often causes a self-limited flu-like illness
* Can have relapses, similar to [[tick-borne relapsing fever]]
* Disease more severe in immunocompromised patients, including meningoencephalitis

== Management ==

* [[Is treated by::Doxycycline]] if no neurologic involvement
* [[Is treated by::Ceftriaxone]] if neurologic involvement
* Also [[Is treated by::azithromycin]]
* Resistant to [[amoxicillin]]

== Further Reading ==

* ''Borrelia miyamotoi'': A Comprehensive Review. Pathogens. 2023 Feb 7;12(2):267. doi: [https://doi.org/10.3390/pathogens12020267 10.3390/pathogens12020267]. PMID: [https://pubmed.ncbi.nlm.nih.gov/36839539/ 36839539]; PMCID: [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc9967256/ PMC9967256].
* Human ''Borrelia miyamotoi'' Infection in North America. Pathogens. 2023 Apr 3;12(4):553. doi: [https://doi.org/10.3390/pathogens12040553 10.3390/pathogens12040553]. PMID: [https://pubmed.ncbi.nlm.nih.gov/37111439/ 37111439]; PMCID: [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc10145171/ PMC10145171].

[[Category:Vector-borne infections]]
[[Category:Borrelioses]]